Research has been conducted on the effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia. The study appears to have investigated the impact of these antibodies on individuals with high cholesterol. The findings of this research are being reported, although the specific results and conclusions are not specified.